Compare IDEXX Laboratories, Inc. (IDXX) vs Teradyne, Inc. (TER) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
IDEXX Laboratories, Inc. vs Teradyne, Inc. — how do they compare? IDEXX Laboratories, Inc. trades at $518 (market cap $40.43B), while Teradyne, Inc. trades at $402.99 (market cap $62.34B). The key difference: Teradyne, Inc. is the larger of the two by market cap, and Teradyne, Inc. pays a 0.13% dividend while IDEXX Laboratories, Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold IDEXX Laboratories, Inc. for 46 Days and Teradyne, Inc. for 37 Days on average.
| IDXX | TER | |
|---|---|---|
Market Cap | $40.43B | $62.34B |
Volume | 692,164 | 3,368,404 |
Sector | Health | Technology |
52-Week High | $766.68 | $483.84 |
52-Week Low | $504.70 | $132.05 |
Typical Hold Time | 46 Days | 37 Days |
Enterprise Value | $41.32B | $62.08B |
Dividend Yield | — | 0.13% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IDEXX Laboratories (IDXX) trades at $518.00, up 2.24% with strong earnings beats in recent quarters. The stock shows bearish technical signals but maintains robust fundamentals with 25.03% net margins and 74.21% ROE. Recent acquisitions like CoVetAI and product expansions highlight growth initiatives. Analyst consensus remains bullish with a $665 price target, though technical indicators suggest near-term caution.
Outlook remains positive driven by diagnostic innovation and recurring revenue growth, but faces headwinds from FX volatility and weaker U.S. vet visits. The 36.06 P/E ratio reflects premium valuation, requiring sustained execution. Risks include competitive pressures and insider selling, while institutional ownership trends show mixed signals.
Teradyne (TER) trades at $402.68, down 2.21% on the day, but maintains a bullish technical outlook with strong support near $388. The company reported robust earnings beats in recent quarters, with Q2 2026 EPS of $2.47 surpassing the $2.09 estimate. Revenue growth is accelerating, projected to reach $4.5 billion in 2026, while net income margins are expected to expand to 25.76%. Recent developments include the launch of the Magnum E2 memory test system and Iris 100 for microLED devices, positioning TER to capitalize on AI and high-performance computing demand.
The investment outlook for TER is positive, driven by strong fundamentals, analyst optimism, and strategic positioning in semiconductor test equipment. Key opportunities include exposure to AI-driven demand and consistent earnings outperformance. Risks involve competitive pressures from firms like KLAC and COHU, cyclical semiconductor industry dynamics, and execution risks in new product launches. With a consensus price target of $461.50 and no sell ratings, Wall Street sentiment remains bullish, though valuation multiples are elevated.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About IDEXX Laboratories, Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →About Teradyne, Inc.
Teradyne provides testing equipment, including automated test equipment for semiconductors, system testing for hard disk drives, circuit boards, and electronics systems and wireless testing for devices. The firm entered the industrial automation market in 2015, into which it sells collaborative and autonomous robots for factory applications. Teradyne serves numerous end markets and geographies directly and indirectly with its products, but its most significant exposure is to semiconductor testing, which made up 71% of 2021 sales. Teradyne serves vertically integrated, fabless, and foundry chipmakers with its equipment.
Read more on TER →
